Anaheim, Calif—In the largest study to date, researchers show that statin therapy to reduce the risk of major vascular events works well in patients at high risk for heart disease. But getting patients to comply with the treatment continues to be a problem, said other investigators.
At the annual Scientific Sessions of the American Heart Association, Rory Collins, MD, of the University of Oxford and lead author of the MRC/BHF Heart Protection Study, said this study showed that statin therapy reduces the risk of myocardial infarction (MI) and ischemia by at least one third across a broad range of patients at high risk for heart disease. The results were seen even in patients with cholesterol readings below national target levels.
Mitka M. Cardiologists Like Statins—More Than Patients Do. JAMA. 2001;286(22):2799-2800. doi:10.1001/jama.286.22.2799-JMN1212-2-1